KMT2D and cancer: As MLL4 (KMT2D) loss of function mutations are among the most common events in human cancer, the results presented here offer a novel mechanism by which these mutations may promote both the initiation and progression of cancer, particularly in the setting of keratinocyte cancers, which collectively outnumber all other human malignancies (16).